What’s Going On With NextCure Stock Wednesday?

All NewsJune 3, 2026

NextCure ($NXTC) rises 2.1% premarket after presenting positive Phase 1 clinical data for ovarian cancer treatment SIM0505 at ASCO.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT